Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.
From the official U.S. FDA label for combined newcastle disease, the active ingredient registered with NAFDAC.
Supports the immune systems response to Lyme disease symptoms.* * Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Supports the immune systems response to Lyme disease symptom
iF PREGNANT OR BREAST-FEEDING, ask a health care professional before use. If symptoms worsen or persist for more than a week, discontinue use and contact a doctor. KEEP OUT OF REACH OF CHILDREN.
Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.
Nobilis IB multi+ND contains Combined Newcastle disease and Avian infectious bronchitis vaccine, Inactivated (see Composition), as emulsion for injection, according to its NAFDAC registration record.
Yes. Nobilis IB multi+ND is listed on the NAFDAC register under registration number A6-100071, and its registration is active as of 5 November 2026.
No WHO falsified or substandard medical product alert currently matches Nobilis IB multi+ND in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number A6-100071, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
Supports the immune systems response to Lyme disease symptoms.* * Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. (Summarised from the official U.S. FDA label for combined newcastle disease. Always follow your doctor or pharmacist.)
Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.